The link between inflammation and cancer has become a key area of research, revealing new therapeutic targets that offer promise for innovative cancer treatments. Chronic inflammation contributes to tumor initiation, progression, and metastasis by creating a microenvironment that supports cancer cell survival and proliferation. This relationship is rooted in findings dating back to the 19th century, when inflammation was first observed in tumor tissues. In modern research, it is recognized that inflammation-induced cellular processes play a crucial role in cancer development, with pathways involving cytokines, immune cells, and protein complexes known as inflammasomes taking center stage in potential treatments
HEALTH ORG & MANAGEMENT JOURNAL
FRONTIERS
.
One such target, the NLRP3 inflammasome, has been shown to regulate inflammatory responses that promote tumor growth and immune evasion in various cancers. This inflammasome is involved in producing pro-inflammatory cytokines like IL-1β and IL-18, which stimulate tumor-supportive immune cells and help create a cancer-friendly microenvironment. However, it can also suppress tumors in certain contexts, reflecting the complexity of inflammasomes in cancer biology. By modulating these inflammasomes, scientists aim to curb inflammation-induced tumorigenesis and potentially halt cancer progression
HEALTH ORG & MANAGEMENT JOURNAL
Therapeutic approaches now target specific inflammatory cytokines, such as IL-6 and TNF-α, due to their role in sustaining tumor-promoting inflammation. Anti-inflammatory drugs and inhibitors targeting these cytokines and inflammasome pathways are under active investigation, with some progressing to clinical trials. Recent data indicate that targeting inflammation could not only shrink tumors but also improve responses to immunotherapies, which often face challenges due to inflammatory resistance mechanisms
FRONTIERS
This focus on inflammation as a therapeutic target marks a significant shift in cancer treatment paradigms, offering hope for more effective, targeted therapies that could improve patient outcomes and minimize side effects.
Comments (8)
Mellisa Doe
What proportion of avocado i should include in my diet if i am having some heart
medication. Please share your insight.
Rayan Kellar
Hi Mellisa, Thank you for asking me. I hope you read the article & liked it. In
the last part I have mentioned it. But I will also mail you details.
Mellisa Doe
What proportion of avocado i should include in my diet if i am having some heart
medication. Please share your insight.
Rayan Kellar
Hi Mellisa, Thank you for asking me. I hope you read the article & liked it. In
the last part I have mentioned it. But I will also mail you details.
Mellisa Doe
As the world continues to fight COVID-19 some property owners are searching
for way they can improve the security of their buildings.
Mellisa Doe
As the world continues to fight COVID-19 some property owners are searching
for way they can improve the security of their buildings.
jhkl
lkjh
jhkl
lkjh